METABOLISM OF 5-FLUOROURACIL (5-FU) IN HUMAN GASTROINTESTINAL CANCER

被引：0
|
作者：
BERNE, M [1 ]
ALMERSJO, O [1 ]
GUSTAVSSON, B [1 ]
机构：
[1] OSTRA SJUKHUSET,DEPT SURG,S-41685 GOTHENBURG,SWEDEN
来源：
ACTA CHIRURGICA SCANDINAVICA | 1983年
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：31 / 31
页数：1
相关论文
共 50 条
  • [31] Modulation of plasma pharmacokinetics of 5-fluorouracil (5-FU) by eniluracil
    Abaogye, EO
    Saleem, A
    Osman, S
    Yap, J
    Harte, RJA
    Purnell, C
    O'Callaghan, M
    Lucas, VS
    Jones, T
    Price, PM
    [J]. BRITISH JOURNAL OF CANCER, 1999, 80 : 95 - 95
  • [32] TREATMENT OF EXPERIMENTAL ACUTE PANCREATITIS WITH 5-FLUOROURACIL (5-FU)
    JOHNSON, RM
    BARONE, RM
    NEWSON, BL
    DASGUPTA, TK
    NYHUS, LM
    [J]. AMERICAN JOURNAL OF SURGERY, 1973, 125 (02): : 211 - 222
  • [33] ALLERGIC CONTACT-DERMATITIS TO 5-FLUOROURACIL (5-FU)
    GOETTE, DK
    ODOM, RB
    [J]. CLINICAL RESEARCH, 1976, 24 (02): : A201 - A201
  • [34] Effect of time interval between surgery and preoperative chemoradiotherapy with 5-fluorouracil (5-FU) or 5-FU/oxaliplatin (5FU/OX) for rectal cancer
    Dolinsky, CM
    Mahmoud, NN
    Mick, R
    Sun, W
    Whittington, RW
    Solin, LJ
    Haller, DG
    Fry, RD
    Metz, JM
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2005, 63 (02): : S277 - S277
  • [35] Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyl-5-FU prodrugs
    Beall, HD
    Sloan, KB
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 217 (1-2) : 127 - 137
  • [36] NONLINEAR PHARMACOKINETIC CHARACTERISTICS OF 5-FLUOROURACIL (5-FU) IN COLORECTAL-CANCER PATIENTS
    SCHAAF, LJ
    DOBBS, BR
    EDWARDS, IR
    PERRIER, DG
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1987, 32 (04) : 411 - 418
  • [37] ANTICOAGULATION AND 5-FLUOROURACIL (5-FU) IN ADVANCED COLON CANCER - CLINICAL AND PHARMACOKINETIC ANALYSIS
    CHLEBOWSKI, R
    GOTA, C
    CHAN, K
    WEINER, J
    BATEMAN, J
    [J]. PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1980, 21 (MAR): : 167 - 167
  • [38] Transdermal delivery of 5-fluorouracil (5-FU) by 1-alkylcarbonyl-5-FU prodrugs
    Beall, HD
    Sloan, KB
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 129 (1-2) : 203 - 210
  • [39] Topical delivery of 5-fluorouracil (5-FU) by 3-alkylcarbonyloxymethyl-5-FU prodrugs
    Roberts, WJ
    Sloan, KB
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 92 (05) : 1028 - 1036
  • [40] Predictive profiling of 5-fluorouracil (5-FU) resistance in metastatic colorectal cancer (mCRC).
    Ichikawa, W
    Takahashi, T
    Suto, K
    Okayama, Y
    Toda, E
    Oka, T
    Okayama, S
    Hirayama, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 261S - 261S
12345